02 Jan 2018
The type 2 diabetes combined therapy of GLP-1, GIP and glucagon was found to protect against neurological degeneration in an Alzheimer’s disease mouse model, according to a study published in Brain Research.
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024